A Phase I Study to Evaluate the Safety and Drug Allergy of HLB3-002 in Healthy Volunteers
Clinical trial NCT06713317 · COMPLETED
Trial details
- NCT number
- NCT06713317
- Sponsor
- Huonslab Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-02
- Primary completion
- 2025-06-27
- Enrollment
- 243
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.